Assessment
Questionnaire

Have a symptom?
See what questions
a doctor would ask.
 
News » New drug treatment for Wilson's disease show's promise
 

New drug treatment for Wilson's disease show's promise

A new drug being tested for treatment of Wilson's disease is showing promising results. Wilson's disease occurs when the body is unable to eliminate copper from the body. The copper levels build up causing toxicity to the liver and brain. Current drugs used to eliminate the copper often causes significant increase in brain damage. The new drug, Tetrathiomolybdate, caused increased brain damage in only 4% of patients compared to 50% of patients when Penicillamine was used. The drug is also being tested for its efficacy in treating cancer, pulmonary fibrosis, psoriasis and cirrhosis.

Source: summary of medical news story as reported by Ivanhoe Broadcast News

Related Disease Topics:

Related Symptom Topics:

Article Source Details

About: New drug treatment for Wilson's disease show's promise

Date: 16 October 2004

Source: Ivanhoe Broadcast News

URL: http://www.news8austin.com/content/headlines/?ArID=122235&SecID=2

Related Medical Topics

This summary article refers to the following medical categories:

More News Topics

  • Prevention of osteoporosis in cystic fibrosis
  • Prisoners complain of inadequate health care
  • Problem of shortage of islet cell donors
  • Prolonged diagnosis causes loss of testicle for adolescent
  • Prolonged NSAIDs usage implicated in increased cancer risk
  • Prolonged use of HIV treatment leads to heart disease and stroke
  • Promiscuity linked to prostate cancer
  • Promised label warning on heart drug still not done after 1 year
  • Promising drugs raise dilemma of whether benefits outweigh the risks
  • Proposed over the counter cholesterol drug still under doubt
  • Prostate cancer active surveillance
  • Prostate cancer incidence increasing in Nigerian men
  • Prostate cancer often caused by lack of exposure to natural sunlight
  • Prostate cancer prognosis may be predicted by measuring levels of beta-catenin
  • Prostate cancer recurrence linked to obesity
  •  

    By using this site you agree to our Terms of Use. Information provided on this site is for informational purposes only; it is not intended as a substitute for advice from your own medical team. The information on this site is not to be used for diagnosing or treating any health concerns you may have - please contact your physician or health care professional for all your medical needs. Please see our Terms of Use.

    Home | Symptoms | Diseases | Diagnosis | Videos | Tools | Forum | About Us | Terms of Use | Privacy Policy | Site Map | Advertise